Scarica l'app Stockscreener
18.90
0.48%
0.09
Dopo l'orario di chiusura:
18.90
Precedente Chiudi:
$18.81
Aprire:
$18.99
Volume 24 ore:
922.21K
Relative Volume:
0.98
Capitalizzazione di mercato:
$972.08M
Reddito:
$312.78M
Utile/perdita netta:
$-143.56M
Rapporto P/E:
-7.026
EPS:
-2.69
Flusso di cassa netto:
$1.22M
1 W Prestazione:
+0.32%
1M Prestazione:
+2.00%
6M Prestazione:
+2.44%
1 anno Prestazione:
-16.81%
Intervallo 1D:
$18.72
$19.62
Intervallo di 1 settimana:
$17.20
$20.13
Portata 52W:
$10.96
$25.95
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Confronta CDNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
18.90 | 967.45M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - MarketScreener
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - MarketScreener
CareDx and 10x Genomics partner on transplant rejection research - Investing.com India
CareDx (NASDAQ:CDNA) Shares Gap DownHere's Why - MarketBeat
Craig-Hallum downgrades CareDx stock rating to Hold from Buy By Investing.com - Investing.com Canada
Craig-Hallum downgrades CareDx stock rating to Hold from Buy - Investing.com
What drives CareDx Inc 1K9 stock priceFinancial Sector Performance & Low Cost Investment Portfolio - earlytimes.in
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
Should CareDx’s Governance Settlement and ESOP Shift Require Action From CareDx (CDNA) Investors? - simplywall.st
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) (CDNA) - Seeking Alpha
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
CareDx (CDNA): Reassessing Valuation After Governance Reform Settlement and Legal Resolution Proposal - Sahm
CareDx (NASDAQ:CDNA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Will CareDx Inc stock benefit from commodity pricesShare Buyback & Capital Efficient Trade Techniques - Улправда
CareDx wins preliminary court approval for derivative settlement - MSN
Short Covering: Why CareDx Inc stock is popular among millennialsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - Улправда
Why CareDx Inc stock is in analyst buy zoneQuarterly Market Review & Free Weekly Chart Analysis and Trade Guides - Улправда
Is CareDx Inc stock a bargain at current levels2025 Pullback Review & Entry and Exit Point Strategies - Улправда
CareDx price target raised to $18 from $14 at Wells Fargo - MSN
Wells Fargo maintains CareDx (CDNA) equal-weight recommendation - MSN
Will CareDx Inc stock outperform Dow Jones index2025 Market Trends & High Win Rate Trade Alerts - Улправда
Why CareDx Inc stock is popular among millennialsMarket Performance Recap & Weekly High Conviction Trade Ideas - Улправда
CareDx (NASDAQ: CDNA) secures preliminary approval for shareholder derivative settlement - Stock Titan
CareDx provides notice of proposed derivative settlement - marketscreener.com
CareDx Provides Notice Of Proposed Derivative Settlement - TradingView — Track All Markets
CareDx Wins Preliminary Court Approval for Derivative Settlement - TipRanks
CareDx, Inc. Reaches Preliminary Settlement in Shareholder Derivative Litigation - TradingView — Track All Markets
CareDx Provides Notice of Proposed Derivative Settlement - Yahoo Finance
Squarepoint Ops LLC Has $2.77 Million Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Transplantation Market to Reach US$ 31.92 Billion by 2032 at 8.6% - openPR.com
CareDx (NASDAQ: CDNA) adopts majority voting and director resignation rules - Stock Titan
CDNA: Wells Fargo Raises Price Target to $18, Maintains Equal-We - GuruFocus
Trading the Move, Not the Narrative: (CDNA) Edition - Stock Traders Daily
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound - Yahoo Finance
Nikko Asset Management Americas Inc. Reduces Position in CareDx, Inc. $CDNA - MarketBeat
CareDx Shares Navigate Conflicting Market Signals - AD HOC NEWS
There's No Escaping CareDx, Inc's (NASDAQ:CDNA) Muted Revenues Despite A 26% Share Price Rise - 富途牛牛
CareDx, Inc. $CDNA Shares Sold by Bellevue Group AG - MarketBeat
CareDx (NASDAQ:CDNA) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
CareDx Reports Strong Q3 2025 Financial Results - MSN
Stocks Showing Improved Relative Strength: CareDx - MSN
CareDx Reforms Get Nod Following $20 Million Investor Class Deal - Bloomberg Law News
Next Century Growth Investors LLC Purchases 850,580 Shares of CareDx, Inc. $CDNA - MarketBeat
Ophir Asset Management Pty Ltd Buys 274,625 Shares of CareDx, Inc. $CDNA - MarketBeat
New York State Common Retirement Fund Acquires 64,175 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Hood River Capital Management LLC - MarketBeat
CareDx, Inc. $CDNA Shares Sold by Divisadero Street Capital Management LP - MarketBeat
Russell Investments Group Ltd. Has $5.06 Million Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
CareDx Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.56%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):